ALL KEYWORDS
Diffuse Large B-Cell Lymphoma
Related Specialists
Showing 3 of 39
Related Fact Sheets
Related Clinical Trials
Showing 2 of 4
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma
- Lymphoma
Phase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
- Leukemia & Hematologic Cancers
Related Departments
Showing 3 of 5